Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1800034	CMAB801注射液	bevacizumab	Injection	Biological Products(2)	New Drug Application	2018-04-13	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	In Review	2018-04-12	view
CXSL1500109	CMAB806	tocilizumab	Injection	Biological Products(2)	New Drug Application	2016-02-16	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	Certificate Issued	2016-11-09	view
CXSL1600025	CMAB809	trastuzumab	Active ingredient	Biological Products(2)	New Drug Application	2016-04-22	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	Certificate Issued	2017-04-20	view
CXSL1700012	CMAB819注射液	Nivolumab	Injection	Biological Products(1)	New Drug Application	2017-05-11	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	Certificate Issued	2017-10-17	view
CXSS2000004	注射用英夫利西单抗	infliximab	Lyophilized	Biological Products(2)	New Drug Application	2020-02-14	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	In Approval	2021-07-05	view
CXSL1500038	重组抗TNFα全人源单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2015-07-29	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	Certificate Issued	2016-06-27	view